FDA Inspection 604389 — Livzon New North River Pharmaceutical Co., Ltd.
The FDA completed an inspection of Livzon New North River Pharmaceutical Co., Ltd. on July 16, 2009 in Qingyuan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Veterinary.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- July 16, 2009
- Fiscal Year
- 2009
- Product Type
- Veterinary
- Project Area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Location
- Qingyuan (China)